Luteolin as a therapeutic option for multiple sclerosis
<p>Abstract</p> <p>Multiple sclerosis (MS) remains without an effective treatment in spite of intense research efforts. Interferon-beta (IFN-β) reduces duration and severity of symptoms in many relapsing-remitting MS patients, but its mechanism of action is still not well understoo...
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2009-10-01
|
| Series: | Journal of Neuroinflammation |
| Online Access: | http://www.jneuroinflammation.com/content/6/1/29 |